Emergent BioSolutions
EBS
#7551
Rank
C$0.60 B
Marketcap
C$11.64
Share price
-0.83%
Change (1 day)
29.82%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2025 (TTM): C$0.23 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are C$0.75 Billion. In 2024 the company made an earning of -C$0.11 Billion, an increase over its 2023 earnings that were of -C$0.9 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$0.23 B-333.34%
2024 -C$0.11 Billion-88.82%
2023 -C$0.9 Billion242.73%
2022 -C$0.27 Billion-153.8%
2021 C$0.48 B-20.43%
2020 C$0.61 B278.02%
2019 C$0.16 B27.11%
2018 C$0.12 B-27.12%
2017 C$0.17 B17.21%
2016 C$0.14 B0.45%
2015 C$0.14 B73.51%
2014 C$85.75 M41.36%
2013 C$60.66 M35.2%
2012 C$44.87 M0.4%
2011 C$44.69 M-56.46%
2010 C$0.10 B76.73%
2009 C$58.07 M32.94%
2008 C$43.68 M-5.62%
2007 C$46.29 M
2005 C$67.02 M269.89%
2004 C$18.11 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$14.81 B 6,307.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$18.39 B 7,856.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.00 B 5,956.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-C$17.31 Million-107.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.12 B-45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-C$0.41 Billion-273.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.17 B 1,273.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel